Ri. Scheinman et al., ROLE OF TRANSCRIPTIONAL ACTIVATION OF I-KAPPA-B-ALPHA IN MEDIATION OFIMMUNOSUPPRESSION BY GLUCOCORTICOIDS, Science, 270(5234), 1995, pp. 283-286
Glucocorticoids are potent immunosuppressive drugs, but their mechanis
m is poorly understood. Nuclear factor kappa B (NF-kappa B), a regulat
or of immune system and inflammation genes, may be a target for glucoc
orticoid-mediated immunosuppression. The activation of NF-kappa B invo
lves the targeted degradation of its cytoplasmic inhibitor, I kappa B
alpha, and the translocation of NF-kappa B to the nucleus. Here it is
shown that the synthetic glucocorticoid dexamethasone induces the tran
scription of the I kappa B alpha gene, which results in an increased r
ate of I kappa B alpha protein synthesis. Stimulation by tumor necrosi
s factor causes the release of NF-kappa B from I kappa B alpha. Howeve
r, in the presence of dexamethasone this newly released NF-kappa B qui
ckly reassociates with newly synthesized I kappa B alpha, thus markedl
y reducing the amount of NF-kappa B that translocates to the nucleus.
This decrease in nuclear NF-kappa B is predicted to markedly decrease
cytokine secretion and thus effectively block the activation of the im
mune system.